Regulation (EU) 2018/1718 of the European Parliament and of the Council of 14 November 2018 amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/regulation/2018/1718@2018-11-14/en
THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 114 and point (c) of Article 168(4) thereof,
Having regard to the proposal from the European Commission,
After transmission of the draft legislative act to the national parliaments,
Having regard to the opinion of the European Economic and Social Committee,
After consulting the Committee of the Regions,
Acting in accordance with the ordinary legislative procedure,
Whereas:
(1) In the context of the United Kingdom’s notification on 29 March 2017 of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union (TEU), the other 27 Member States, meeting on 20 November 2017 in the margins of the Council, selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency (the Agency).
(2) Having regard to Article 50(3) TEU, the Agency should take its new seat as of 30 March 2019.
(3) To ensure the proper functioning of the Agency in its new location, a headquarters agreement should be concluded between the Agency and the Netherlands before the Agency takes up its new seat.
(4) It is to be welcomed that the authorities of the Netherlands are making efforts to ensure the operational effectiveness, continuity and uninterrupted functioning of the Agency during and after the relocation. Nevertheless, given the extraordinary situation, the Agency may have to temporarily focus on its core tasks and prioritise other activities according to their impact on public health and the Agency’s ability to function.
(5) The Commission should monitor the overall relocation process of the Agency to its new seat and assist that process within the limits of its competences.
(6) To give the Agency sufficient time to relocate, this Regulation should enter into force as a matter of urgency.
(7) Regulation (EC) No 726/2004 of the European Parliament and of the Council should therefore be amended accordingly,
HAVE ADOPTED THIS REGULATION:
Article 1
The following Article is inserted in Regulation (EC) No 726/2004:
Article 1
Article 71a The Agency shall have its seat in Amsterdam, the Netherlands.
The competent authorities of the Netherlands shall take all necessary measures to ensure that the Agency is able to move to its temporary location no later than 1 January 2019 and that it is able to move to its permanent location no later than 16 November 2019. The competent authorities of the Netherlands shall submit a written report to the European Parliament and the Council on the progress on the adaptations to the temporary premises and on the construction of the permanent building by 17 February 2019, and every three months thereafter, until the Agency has moved to its permanent location..
Article 2
This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union. This Regulation shall apply from 30 March 2019.
This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Strasbourg, 14 November 2018. For the European Parliament The President A. Tajani For the Council The President K. Edtstadler
Versions
Cited by
- Council Decision (EU) 2026/1535 of 25 June 2026 on the position to be adopted on behalf of the European Union within the Joint Committee established by the Agreement between the European Community and the Principality of Monaco on the application of certain Community acts on the territory of the Principality of Monaco concerning amendments to the Annex to that Agreement Decision · Grade B
Regulation (EU) 2018/1718 of the European Parliament and of the Council of 14 November 2018 amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency (OJ L 291, 16.11.2018, p. 3);
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2023 C/2024/5462 Notice · Grade B
Included in the guarantees given as at 31 December 2023 are EUR 2,1 billion of signed but undisbursed loans for which future disbursements are conditional on approval by the EU. The EU ELM guarantee relating to loans granted by the EIB is limited to 65 % of the outstanding balances for agreements signed after 2007 (mandates 2007-2013 and 2014-2021). For agreements made before 2007, the EU guarantee is limited to a percentage of the ceiling of the credit lines authorised, in most cases 65 % but also 70 %, 75 % or 100 %. Where the ceiling is not reached, the EU guarantee covers the full amount.
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2018 (2019/C 327/01) Notice · Grade B
ECSC in Liquidation loans granted on borrowed funds are not covered by an EU budgetary guarantee. Instead, they are covered by financial assets of the ECSC in Liquidation – see note 2.4.1. Guarantees given for EU financial instruments EUR million 31.12.2018 31.12.2017 Horizon 2020 1467 1297 Risk Sharing Finance Facility 642 654 Connecting Europe Facility 579 490 Other 29 32 Total 2717 2473 As mentioned in Article 210(1) FR, the budgetary expenditure linked to a financial instrument and the financial liability of the EU shall in no case exceed the amount of the relevant budgetary commitment mad
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union 2019 2020/C 384/01 Notice · Grade B
Guarantees given for EU financial instruments EUR million 31.12.2019 31.12.2018 Horizon 2020 1584 1467 Risk Sharing Finance Facility 110 642 Connecting Europe Facility 684 579 Other 38 29 Total 2416 2717 As mentioned in Article 210(1) FR, the budgetary expenditure linked to a financial instrument and the financial liability of the EU shall in no case exceed the amount of the relevant budgetary commitment made for it, thus excluding contingent liabilities for the budget. In practice, it means that these liabilities have a counter-part on the asset side of the balance sheet or are covered by the
- P8_TA(2018)0427 Relocation of the European Medicines Agency ***I European Parliament legislative resolution of 25 October 2018 on the proposal for a regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency (COM(2017)0735 — C8-0421/2017 — 2017/0328(COD)) (Ordinary legislative procedure: first reading) 2020/C 345/53 Notice · Grade B
(As an agreement was reached between Parliament and Council, Parliament's position corresponds to the final legislative act, Regulation (EU) 2018/1718.)
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Annual Accounts of the European Union 2020 2021/C 436/01 Notice · Grade B
In accordance with Article 143 of the Withdrawal Agreement, the UK shall be liable to the Union for its share of contingent financial liabilities related to the loans for financial assistance (EFSM, MFA, BOP and Euratom) approved/decided at the withdrawal date, 31 January 2020. Article 143 requires that in case of a default under a loan for financial assistance that has been approved before the withdrawal date, the UK would be liable to the Union for its share of payments made by the Union under the defaulted operation, unless this could be covered by the UK share of provisioning held in the g
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2024 C/2025/4944 Notice · Grade B
Included in the guarantees given as at 31 December 2024 are EUR 2,1 billion of signed but undisbursed loans for which future disbursements are conditional on approval by the EU. The EU ELM guarantee relating to loans granted by the EIB is limited to 65 % of the outstanding balances for agreements signed after 2007 (mandates 2007-2013 and 2014-2021). For agreements made before 2007, the EU guarantee is limited to a percentage of the ceiling of the credit lines authorised, in most cases 65 % but also 70 %, 75 % or 100 %. Where the ceiling is not reached, the EU guarantee covers the full amount.
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2022 C/2023/2 Notice · Grade B
The amounts disclosed on the first three lines of the table above relate to the Heading 2A (Economic, Social and Territorial Cohesion), Heading 3 (Natural Resources and Environment) and Heading 4 (Migration and Border Management) of the MFF 2021–2027 . They represent the outstanding amounts that the EU will commit budgetarily and then pay after 31 December 2022. The RRF is a key programme of NGEU, the EU Recovery Instrument. It was established by Regulation (EU) 2021/241 of the European Parliament and of the Council. It finances reforms and investments in Member States from the start of the co
- Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2021 2022/C 399/01 Notice · Grade B
8 8 Other contingent assets 98 58 Total 393 384 Performance guarantees are requested to ensure that beneficiaries of EU funding meet the obligations of their contracts with the EU. BUDGETARY AND LEGAL COMMITMENTS This note provides information on the budgetary process and future funding needs and not on liabilities existing as at 31 December 2021. The Multiannual Financial Framework (MFF) agreed by the Member States defines the programmes and sets out the heading ceilings for commitment appropriations and the total for payment appropriations within which the EU may enter into budgetary and leg